S1-Fc fusion protein

N/A

Report date: 2022/05/24 15:09:15
NME

Base Information

Drug NameS1-Fc fusion protein
Drug Alias NameS-1-Fc fusion proteinS1-Fc fusion protein
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoronavirus spike glycoprotein inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAbmax Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAbmax Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A